Alcon announced today that it entered into a definitive merger agreement through which it intends to acquire Lensar. The acquisition includes the Ally robotic cataract laser treatment system, Lensar’s proprietary Streamline software technology and the Lensar legacy laser system. These technologies help to build Alcon’s femtosecond laser-assisted cataract surgery (FLACS) offering. Under the agreement, Alcon […]
Alcon
Alcon acquires Belkin Vision for up to $385M
Alcon this week announced it is acquiring Belkin Vision for up to $385 million. The deal includes an upfront consideration of $81 million, a cash payment of approximately $65 million, and the potential for up to $385 million in payments contingent upon rigorous sales-based milestones. Alcon is acquiring Belkin Vision’s Direct Selective Laser Trabeculoplasty (DSLT) […]
Sight Sciences to earn $34M from Alcon patent infringement suit
Sight Sciences (Nasdaq:SGHT) announced today that it received a jury trial verdict awarding it $34 million from a patent infringement case against Alcon. The company filed the case on Sept. 16, 2021, against Alcon, Alcon Vision, Alcon Research and Ivantis (collectively Alcon) in the U.S. Menlo Park, California-based Sight Sciences asserted that Alcon’s sale of […]
10 new, innovative medical devices to watch for in 2024
By Senior Editor Danielle Kirsh and Associate Editor Sean Whooley Significant medical device launches are coming in 2024. Think pulsed field ablation, diabetes treatment tech, surgical robotics and more. Pulsed field ablation news took over at the end of 2023 and the start of 2024, with Medtronic and Boston Scientific garnering significant regulatory approvals. Surgical […]
Alcon stock dips on Q3 misses, tightened guidance
Alcon shares fell this morning on third-quarter results that missed the consensus forecast. Shares of ALC dipped 6.9% at $69.82 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The Geneva, Switzerland–based eye care device company posted profits of $204 […]
Alcon says sales could grow up to 8% this year
Alcon (SIX/NYSE:ALC) reported fourth-quarter revenues that beat the consensus of Wall Street analysts, with earnings in-line with expectations. The Geneva-based eye care tech company yesterday evening also released 2023 guidance that was ahead of The Street’s consensus. However, Alcon’s actual Q4 results showed slowing sales growth as the company swung to a loss. Alcon lost […]
Alcon to pay $199M to J&J to settle patent dispute
Alcon (SIX/NYSE: ALC) recently announced that it has settled a patent dispute with J&J Surgical Vision. The $199 million settlement, announced Feb. 12, ends a lawsuit that J&J had filed in June 2020 in U.S. District Court in Delaware. J&J Surgical Vision had claimed that Alcon femtosecond laser-assisted cataract surgery devices, including the company’s LenSx […]
Alcon to soon launch reusable lens for astigmatism
Alcon (NYSE:ALC) announced today that it plans to launch its Total30 reusable contact lens for people with astigmatism. Geneva, Switzerland-based Alcon designed Total30 with its proprietary water gradient material. This enables a gradual increase to nearly 100% water on the outermost surface. With this technology, the lens ensures that nothing touches the eye but a […]
Alcon stock rises on Q3 EPS beat
Alcon (NYSE:ALC) shares ticked up this morning on third-quarter results that came in ahead of the consensus earnings forecast. Shares of ALC were up more than 4% at $66.47 apiece by early afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up more than […]
5 top ophthalmic device innovations you need to know
Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space. It may not be a new wave, but medtech companies continue to improve upon technologies for the human eye. Implants, lenses and more comprise the space’s latest innovations, with a number of companies finding new ways to fix old […]
Alcon lowers its 2022 forecast amid strong dollar
Alcon (SIX/NYSE:ALC) posted Street-beating second quarter results but lowered its 2022 guidance amid a challenging macroeconomic environment. The Geneva-based eye care tech giant announced yesterday evening that it earned $148 million, or 30¢ per share, off $2.22 billion in sales during the quarter ended June 30, 2022, for a bottom-line decline of 2% and a […]
